Rafale Fighter Jets.  (File Photo | Shekhar Yadav, EPS)
Telangana

Safran to maintain Rafale engines in Hyderabad

The facility, Safran Aircraft Engine Services India, will be dedicated exclusively to servicing the M88 military engines used in Dassault Rafale fighter jets.

Express News Service

HYDERABAD: French aerospace company Safran has announced plans to establish a new Maintenance, Repair and Overhaul (MRO) facility in Hyderabad. The facility, Safran Aircraft Engine Services India, will be dedicated exclusively to servicing the M88 military engines used in Dassault Rafale fighter jets. This will be the first such facility for the M88 engine outside France.

The announcement was made by Safran general manager Pierre Fernandez in the presence of IT and Industries Minister D Sridhar Babu during a high-level roundtable organised by the Indo-French Chamber of Commerce & Industry (IFCCI) at the Secretariat on Tuesday.

The facility is expected to create around 150 new jobs by the end of next year, with the possibility of adding a further 750 jobs in later phases.

Safran’s Hyderabad operations are set to become a central hub for the production and export of critical components for Rafale engines. Support from the state government has positioned Hyderabad as a developing aerospace hub.

Safran is expanding its operations in Telangana with a major investment in Hyderabad. The company has already established two production facilities in the city.

The roundtable saw participation from senior state government officials and a delegation of French business representatives. Discussions focused on investment opportunities in sectors such as engineering, AI, clean energy and manufacturing.

On the occasion, Sridhar Babu spoke of the importance of Indo-French collaborations and urged IFCCI to explore opportunities in the Future City project.

Sunetra to be sworn in Maharashtra Dy CM today, uncertainty on merger

INTERVIEW | Naïve protectionism under UPA cost India billions: Goyal

Medical colleges miss SC order on interns’ stipend, NMC missing in action

Explain rationale of pilot duty relaxation norms: Delhi HC to DGCA

Stem cell treatment for autism malpractice, only clinical trials allowed: SC

SCROLL FOR NEXT